297 results
Page 2 of 15
8-K
EX-99.1
ng8837xjbn6821
27 Oct 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.2
rsmnbj6y31o7lupo0
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
EX-99.1
v091p
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
EX-99.1
ry0elvf2
28 Jul 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
td79vk0 6jgv4pu
14 Jun 22
Other Events
7:30am
8-K
EX-99.1
mdbumcdfmfub7i34j
28 Apr 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
o69l9r6cq 8a4i7j276a
5 Apr 22
Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors
4:16pm
8-K
EX-99.1
5gu9n de09
4 Apr 22
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
7:35am
8-K
EX-99.1
9hotwcnct7ile8okctcm
10 Feb 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
bq6giad
10 Jan 22
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates
7:01am
8-K
EX-99.1
ar0f mwpx
4 Jan 22
Alnylam Announces Promotion of Dr. Akshay Vaishnaw to President
4:16pm
8-K
EX-10.1
0cinu0g 602
20 Dec 21
Departure of Directors or Certain Officers
4:15pm